African Surgical Outcomes Study (ASOS)

计划入组 11,422 人 · 首次发布于 2017 年 2 月 7 日

AXOS and Microbial Metabolites in CKD

计划入组 40 人 · 首次发布于 2014 年 5 月 19 日

Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)

计划入组 50 人 · 首次发布于 2011 年 3 月 4 日

Amos-1000

APP ASOs(University College London)

Ataxin-7 ASOs(Ionis Pharmaceuticals)

Aros Pharma ApS

Denmark

Atos Medical AB

Sweden

Acumen Pharmaceuticals Advances Sabirnetug in Alzheimer's Disease Treatment

Acumen's ACU193 Shows Promise as First-in-Class Alzheimer's Treatment Targeting Toxic Amyloid Oligomers

Acumen Pharmaceuticals Advances Alzheimer's Pipeline with JCR Partnership and ALTITUDE-AD Phase 2 Trial